CHANGE IN BONE MINERAL DENSITY (BMD) OR BONE TURNOVER MARKERS (BTM) DID NOT PREDICT RISK OF VERTEBRAL FRACTURE AFTER DISCONTINUATION OF ALENDRONATE IN THE FLEX STUDY

被引：0
|
作者：
Chang, S. [1 ]
Bauer, D. [2 ]
Black, D. [2 ]
机构：
[1] Univ Calif San Francisco, Clin & Translat Sci Inst, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P612
引用
收藏
页码：S377 / S377
页数：1
相关论文
共 50 条
  • [1] Baseline bone mineral density (BMD) and bone turnover markers (BTM) to predict 2-year change in BMD in systemic lupus erythematosus (SLE).
    Lee, C
    Almagor, O
    Dunlop, DD
    Langman, CB
    Price, H
    Spies, S
    Chadha, AB
    Ramsey-Goldman, R
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S304 - S304
  • [2] Effects of Denosumab vs Alendronate on Bone Mineral Density (BMD), Bone Turnover Markers (BTM), and Safety in Women Previously Treated with Alendronate.
    Kendler, D. L.
    Benhamou, C. L.
    Brown, J. P.
    Lillestol, M.
    Roux, C.
    Man, H. S.
    Siddhanti, S.
    Martin, J. San
    Bone, H. G.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S473 - S473
  • [3] Bone mineral density (BMD) and fracture risk reduction with alendronate
    Yates, J
    Faulkner, K
    Meunier, PJ
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S204 - S205
  • [4] Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk
    Sarkar, S
    Reginster, JY
    Crans, GG
    Diez-Perez, A
    Pinette, KV
    Delmas, PD
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (03) : 394 - 401
  • [5] RELATIONSHIP BETWEEN REDUCTION IN BONE TURNOVER MARKERS (BTM) AND CHANGE IN BONE MINERAL DENSITY (BMD) IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS TREATED WITH DENOSUMAB
    Eastell, R.
    Christiansen, C.
    Grauer, A.
    Kutilek, S.
    Libanati, C.
    McClung, M.
    Resch, H.
    Siris, E.
    Uebelhart, D.
    Reid, I.
    Wang, A.
    Weryha, G.
    Cummings, S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 185 - 186
  • [6] Change in bone turnover markers following discontinuation of long-term alendronate in FLEX.
    Schwartz, AV
    Bauer, DC
    Garnero, P
    Santora, AC
    Palermo, L
    Black, DM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S281 - S281
  • [7] Changes in bone mineral density, bone turnover markers, and vertebral fracture risk reduction with once weekly teriparatide
    Tanaka, Shiro
    Kuroda, Tatsuhiko
    Sugimoto, Toshitsugu
    Nakamura, Toshitaka
    Shiraki, Masataka
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (05) : 931 - 936
  • [8] Comparison of biochemical markers of bone turnover and bone mineral density between hip fracture and vertebral fracture
    Takahashi, M
    Naitou, K
    Ohishi, T
    Nagano, A
    [J]. JOURNAL OF CLINICAL DENSITOMETRY, 2003, 6 (03) : 211 - 218
  • [9] Baseline bone mineral density (BMD) and bone turnover markers to predict 2-year change in BMD in systemic lupus erythematosus.
    Lee, C
    Almagor, O
    Dunlop, DD
    Langman, CB
    Price, H
    Spies, S
    Chadha, AB
    Ramsey-Goldman, R
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S611 - S612
  • [10] Multiple measurements of markers of bone turnover predict change in bone mineral density.
    Hannon, RA
    Greenfield, DM
    Eagleton, AC
    Eastell, R
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S405 - S405
12345